Intelligent Bio Solutions Files Definitive Proxy Statement
Ticker: INBS · Form: DEF 14A · Filed: Apr 1, 2025 · CIK: 1725430
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, corporate-governance
TL;DR
IBSI filed its proxy statement - shareholder vote incoming.
AI Summary
Intelligent Bio Solutions Inc. filed a Definitive Proxy Statement (DEF 14A) on April 1, 2025. The filing concerns the company's proxy materials, which are typically used for shareholder meetings to vote on corporate matters. The company, formerly known as GBS Inc., is based in New York and operates in the surgical and medical instruments sector.
Why It Matters
This filing is a standard regulatory requirement for public companies, providing shareholders with information necessary to vote on company matters, ensuring transparency and corporate governance.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing, which is a standard disclosure document for public companies and does not inherently indicate new risks.
Key Players & Entities
- INTELLIGENT BIO SOLUTIONS INC. (company) — Registrant
- GBS Inc. (company) — Former company name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former company name
- 0001641172-25-002077.txt (document) — Filing document identifier
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by a company to solicit proxies from its shareholders for an upcoming shareholder meeting, providing details on matters to be voted upon.
When was this DEF 14A filed by Intelligent Bio Solutions Inc.?
This DEF 14A was filed on April 1, 2025.
What was Intelligent Bio Solutions Inc. formerly known as?
Intelligent Bio Solutions Inc. was formerly known as GBS Inc. and prior to that, Glucose Biosensor Systems (Greater China) Holdings, Inc.
What is the business address of Intelligent Bio Solutions Inc.?
The business address of Intelligent Bio Solutions Inc. is 135 W 41ST ST, FLOOR 5, NEW YORK, NY 10036.
Under which section of the SEC Act is this filing made?
This filing is made pursuant to Section 14(a) of the Securities Exchange Act of 1934.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 1, 2025 regarding INTELLIGENT BIO SOLUTIONS INC. (INBS).